IDEX (IEX) has drawn investor attention after recent share price moves, with the stock showing mixed returns over the past month and past 3 months, prompting a closer look at its current valuation setup.
See our latest analysis for IDEX.
At around $197.90, IDEX’s recent 1 day and 7 day share price declines of 2.67% and 5.52% sit against a 90 day share price return of 11.47% and year to date share price return of 10.52%. Longer multi year total shareholder returns have been more muted, which suggests that short term momentum has cooled after earlier strength.
If this mixed picture has you looking beyond a single name, it could be a moment to broaden your watchlist with 20 top founder-led companies as potential long term compounders to research next.
With IDEX trading near $197.90, an intrinsic value gap of about 23% and a 14% discount to the average analyst target raise a key question: is the stock offering a genuine entry point, or is future growth already priced in?
Most Popular Narrative: 11.5% Undervalued
With IDEX last closing at $197.90 against a narrative fair value of $223.54, the current setup reflects a modest valuation gap that hinges on how future execution plays out.
The company is implementing proactive cost-saving measures, targeting $20 million in savings on top of previous initiatives. This focus on platform optimization and organizational delayering may improve net margins by reducing operating expenses.
Curious what kind of revenue growth, margin profile, and future earnings multiple are baked into that fair value? The narrative leans on steady compounding rather than stretch assumptions, and the discount rate choice quietly shapes how attractive that $223.54 figure looks.
Result: Fair Value of $223.54 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, this depends on tariffs that are expected to impact costs by US$100 million, as well as ongoing weakness in areas like semiconductors and agriculture not worsening materially.
Find out about the key risks to this IDEX narrative.
Another Lens on Valuation
That 11.5% gap to narrative fair value is one perspective. Our DCF model provides another, with a fair value of $255.99 that is above the current $197.90 price and suggests IDEX may be trading at a deeper discount. Which version of “undervalued” do you put more weight on?
Look into how the SWS DCF model arrives at its fair value.
Next Steps
If this mix of fair values and risks leaves you uncertain, it may be helpful to review the underlying data yourself and decide on your own stance. A good place to start is 3 key rewards.
Ready to hunt for your next idea?
If you stop with just one stock, you could miss other opportunities that better fit your goals, risk tolerance, and income needs.
- Target resilient cash generators by reviewing our 50 high quality undervalued stocks that pair quality fundamentals with more appealing prices.
- Prioritize stability and balance sheet strength through the solid balance sheet and fundamentals stocks screener (41 results), especially if you want businesses with room to handle shocks.
- Strengthen your income watchlist with the 16 dividend fortresses, focusing on companies offering higher yields that may support regular cash returns.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com